Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: A literature survey

Journal of Hypertension

Volumn 19, Issue 6, 2001, Pages 1001-1006

  Christensen, Kent L ^a,b   Mulvany, Michael J ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antihypertensive therapy; Essential hypertension; Gluteal biopsies; Haemodynamics; Minimum vascular resistance; Resistance arteries

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HEART OUTPUT; HEMODYNAMICS; HORMONAL REGULATION; HUMAN; HYPOTENSION; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; REVIEW; SHEAR STRESS; VASODILATATION;

EID: 0035019959     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200106000-00002     Document Type: Review

References (62)

1. Borderline hypertension: Relationship between age hemodynamics and circulating catecholamines
2. Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise
3. Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human esential hypertension
4. The hemodynamic importance of structural vascular changes in essential hypertension
5. Adaptive structural changes of the vascular wails in hypertension and their relation to the control of the peripheral resistance
6. A vascular abnormality in hypertension: A study of blood flow in the forearm
7. Coronary circulation in arterial hypertension
8. Noninvasive estimation of increased structurally based resistance to flow in the skin of subjects with essential hypertension
9. Physiological aspects of primary hypertension
10. Evidence for increased media thickness, increased neuronal amine uptake and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives
11. Small artery structure in hypertension: Dual process of remodeling and growth
12. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension
13. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients
14. 'Structural factor' in primary and secondary hypertension
15. Histology of subcutaneous small arteries with essential hypertension
16. Vascular remodelling
17. The debate on the amplifier hypothesis - Some comments
18. The amplifier hypothesis: Permission to dissent?
19. Enhanced total peripheral vascular responsiveness in hypertension accords with the amplifier hypothesis
20. Improvement of coronary flow reserve after longterm therapy with enalapril
21. Resistance vessel growth and remodeling: Cause or consequence in cardiovascular disease
22. Blood pressure stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
23. Reversal of cardiovascular structural changes during long-term antihypertensive therapy
24. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure
25. Structural properties of rat mesenteric small arteries after 4-weeks exposure to elevated or reduced blood flow
26. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism
27. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure
28. Hemodynamics in hypertension at rest and during exercise
29. Non-invasive measurement of endothelial function: Effect on brachial artery dilatation of graded endothelial dependent and independent stimuli
30. Resistance to blood flow at maximal vasodilatation
31. Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker labetalol
32. Effect of long-term beta-adrenergic blockade on calf blood flow in hypertensive patients
33. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: Different effects of enalapril and hydrochlorothiazide
34. Differences between the effects of metoprolol and prazosin on the forearm vasculature in primary hypertension
35. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment
36. Time course of the effects of temocapril on cardiovascular structure and function in patients with essential hypertension
37. Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: Importance of aldosterone response
38. Effects of cilazapril on vascular structure and function in essential hypertension
39. Plethysmographic effects of doxazosin in essential hypertensive patients
40. Vasodilator effects of enalapril in patients with arterial hypertension
41. Regression of structural vascular changes in hypertensives after captopril treatment
42. Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation
43. Blood pressure reduction and vascular adaptation
44. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system
45. Hemodynamics of metoprolol and pindolol in systemic hypertension with particular reference to reversal of structural vascular changes
46. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive patients with left ventricular hypertrophy
47. Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment
48. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine
49. Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril
50. Cardiovascular and renal effects of long-term antihypertensire treatment
51. Structure and function of small arteries of essential hypertensive patients following chronic treatment with once-a-day nifedipine
52. Effects of long-term antihpertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy
53. Effect of antihypertensive treatmenton cardiac and subcutaneous artery structure. A comparison between calcium channels blocker and thiazidebased regimens
54. Effects of drug treatment on human resistance arteriole morphology in essential hypertension: Direct evidence for structural remodelling of resistance vessels
55. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment
56. Effects of a betablocker or a converting enzyme inhibitor on resistance arteries in essential hypertension
57. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril
58. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension
59. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
60. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats
61. The location of resistance arteries
62. The role of the resistance arteries in the control of peripheral resistance